Kaye Edward M. MD Insider Trading Activity
Kaye Edward M. MD has been net-selling over the last 12 months with 0 purchases and 23 sales across 2 different companies.
STOK is the most-traded position with 18 trades. The largest single transaction was a sale of CYTK for $1.9M on Dec 1, 2025.
Performance Scorecard
Forward stock performance after each transaction by Kaye Edward M. MD. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -6.3% | 17% | 24 |
| 90 days | — | -21.1% | 8% | 24 |
| 120 days | — | -19.7% | 8% | 24 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Kaye Edward M. MD bought and sold STOK.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Dec 8, 2025 | STOK | Sell | 3,825 | $31.44 | $120K | −6.1% | Director | |
Dec 8, 2025 | STOK | Sell | 8,274 | $32.52 | $269K | −14.1% | Director | |
Dec 8, 2025 | STOK | Sell | 1,331 | $33.10 | $44K | −2.6% | Director | |
Dec 5, 2025 | STOK | Sell | 1,681 | $31.15 | $52K | −2.6% | Director | |
Dec 5, 2025 | STOK | Sell | 6,367 | $31.33 | $199K | −9.0% | Director | |
Dec 5, 2025 | STOK | Sell | 500 | $31.85 | $16K | −0.8% | Director | |
Dec 4, 2025 | STOK | Sell | 5,222 | $30.76 | $161K | −6.7% | Director | |
Dec 4, 2025 | STOK | Sell | 1,231 | $31.32 | $39K | −1.7% | Director | |
Dec 3, 2025 | STOK | Sell | 651 | $30.85 | $20K | −1.3% | Director | |
Dec 3, 2025 | STOK | Sell | 419 | $30.34 | $13K | −0.8% | Director | |
Dec 2, 2025 | STOK | Sell | 661 | $29.56 | $20K | −1.2% | Director | |
Dec 2, 2025 | STOK | Sell | 405 | $30.14 | $12K | −0.8% | Director | |
Dec 1, 2025 | CYTK | Sell | 28,064 | $66.72 | $1.9M | −73.8% | Director | |
Nov 11, 2025 | CYTK | Sell | 5,175 | $65.08 | $337K | −34.2% | Director | |
Oct 8, 2025 | STOK | Sell | 25,000 | $30.00 | $750K | −33.7% | Director | |
Oct 6, 2025 | CYTK | Sell | 6,757 | $60.00 | $405K | −40.9% | Director | |
Oct 3, 2025 | STOK | Sell | 42,461 | $25.09 | $1.1M | −46.4% | Director | |
Sep 30, 2025 | CYTK | Sell | 6,695 | $55.08 | $369K | −28.8% | Director | |
Sep 3, 2025 | STOK | Sell | 45,996 | $20.13 | $926K | −33.4% | Director | |
Sep 2, 2025 | STOK | Sell | 14,860 | $20.14 | $299K | −9.7% | Director | |
Sep 2, 2025 | CYTK | Sell | 6,756 | $50.00 | $338K | −22.5% | Director | |
Aug 29, 2025 Filed 3d late | STOK | Sell | 1,029 | $20.00 | $21K | −0.7% | Director | |
Aug 18, 2025 | STOK | Sell | 12,126 | $18.24 | $221K | −7.3% | Director | |
Jun 5, 2025 | CYTK | Sell | 3,636 | $32.10 | $117K | −10.9% | Director |
Top Companies Traded
Other insiders at Stoke Therapeutics, Inc.
5 other tracked filers at STOK.